Specify a stock or a cryptocurrency in the search bar to get a summary
Dermapharm Holding SE
DMPDermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG. Address: Lil-Dagover-Ring 7, Grünwald, Germany, 82031
Analytics
WallStreet Target Price
47.04 EURP/E ratio
20.7468Dividend Yield
5.2 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DMP
Dividend Analytics DMP
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
55 %Dividend History DMP
Stock Valuation DMP
Financials DMP
Results | 2019 | Dynamics |